Skip to main content
. Author manuscript; available in PMC: 2007 Sep 21.
Published in final edited form as: Diabetes. 2007 Mar;56(3):786–794. doi: 10.2337/db06-0187

Table 4.

Fatty acid composition of cardiac lipids

Fatty acid COMPOSITION (%)
Heart Mitochondria
Heart Phospholipids
Non phosphorous Lipids
Control AMPKα2−/− Control AMPKα2−/− Control AMPKα2−/−
16:0 13.4±0.6 14.6±0.7 14.2±0.9 16.4±0.5 19.8±0.5 18.1±0.4
16:1 w9 1.1±0.2 1.0±0.3 0.3±0.1 0.35±0.03 6.2±0.7 4.5±0.3
18:0 18±1 17±1 21±1 21±1 8.9±0.3 9±1
18:1 w9 6.7±0.3 7.0±0.2 6.3±0.3 6.3±0.3 19.0±0.4 22.0±0.4*
18:1 w7 2.51±0.03 2.7±0.1 2.26±0.04 2.5±0.1 1.4±0.1 1.5±0.3
18:2 w6 LA 19.2±0.6 16.8±0.4* 18.0±0.2 16.3±0.5* 20.1±1.5 24.3±0.3*
20:4 w6 4.5±0.2 4.3±0.2 5.2±0.2 4.9±0.3 3.0±0.1 2.6±0.4
22:5 w3 1.02±0.03 1.2±0.1 1.1±0.1 4.1±3.1 1.5±0.1 1.5±0.4
22:6 w3 30±2 31±2 28±2 24±1 5.1±0.4 5.4±0.6
SFA 32±1 33±1 36±2 34±5 36±1 39±5
MUFA 12±1 11±1 9.7±0.3 9±1 31±1 36±6
PUFA w6 25.1±0.5 22.5±0.6* 25.2±0.4 20±3 25±1 33±5
PUFA w3 31±2 33±2 29±2 24±4 8.1±0.3 9±1

Values are means ± S.E.M.

*

p<0.05. SFA: saturated fatty acids. MUFA, mono-unsaturated fatty acids. PUFA: polyunsaturated fatty acids. LA, linoleic acid. Three control and three AMPKα2−/− mice were used.